Literature DB >> 2746566

Budd Chiari syndrome, visceral arterial occlusions, recurrent fetal loss and the "lupus anticoagulant" in systemic lupus erythematosus.

R A Asherson1, R P Thompson, N MacLachlan, E Baguley, P Hicks, G R Hughes.   

Abstract

A 30-year-old Chinese woman had been diagnosed as having systemic lupus erythematosus (SLE) at age 25 after 4 spontaneous abortions, all between 8 and 12 weeks of gestation. A year later she developed mild jaundice and at laparotomy, nodular enlargement of the right lobe of the liver and splenomegaly were seen. She was found to have a "lupus anticoagulant" and false positive test for syphilis (VDRL), but persistently negative antibodies to cardiolipin. Angiography demonstrated occlusion and stenoses of visceral abdominal arteries and hepatic venography also showed evidence of hepatic venous occlusions. She subsequently developed thyrotoxicosis which was treated with carbimazole, followed by radioactive iodine. The SLE and lupus anticoagulant were treated with systemic steroids (prednisolone) and anticoagulation (warfarin).

Entities:  

Mesh:

Year:  1989        PMID: 2746566

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Anticardiolipin antibody negative occlusive vascular retinopathy in systemic lupus erythematosus.

Authors:  P H Dessein; R F Gledhill; R A Asherson
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

Review 2.  Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies.

Authors:  M S Cappell; N Mikhail; N Gujral
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

3.  Splenic infarction associated with anticardiolipin antibodies in a patient with acquired immunodeficiency syndrome.

Authors:  M S Cappell; T Simon; M Tiku
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

4.  A case of Budd-Chiari syndrome with high antiphospholipid antibody in a patient with systemic lupus erythematosus.

Authors:  Y Y Yun; K A Yoh; H I Yang; S H Park; S H Lee; C S Cho; H Y Kim
Journal:  Korean J Intern Med       Date:  1996-01       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.